---
canonical_name: Panthenol
alternate_names: Dexpanthenol, D-Panthenol, DL-Panthenol, Provitamin B5, Pantothenol, Pantothenyl Alcohol, Bepanthen, Bepanthol
canonical_topic: Panthenol for Health & Longevity
short_topic_lc: panthenol
creation_date: 2026-1011-0632
creator_ai_fullname: Opus 5.5
---

# Panthenol for Health & Longevity
<section id="top" markdown="1"></section>
Evidence Review created on 10/11/2026 using [AI4L](https://github.com/forever-healthy/AI4L) / Opus 5.5  

**Also known as:** Dexpanthenol, D-Panthenol, DL-Panthenol, Provitamin B5, Pantothenol, Pantothenyl Alcohol, Bepanthen, Bepanthol

  
## Motivation

<!-- Author statement: This Motivation section was written only after all other sections of the review were completed, so that it reflects the full scope of the topic. -->

Panthenol is the alcohol form of vitamin B5 (pantothenic acid), and the body converts it into that vitamin. It is used mostly in skin creams and wound ointments. Its appeal is simple: it is inexpensive, easy to find and has a reputation for being gentle on dry, irritated or freshly treated skin.

Panthenol has been sold for skin care since the late 1940s and is now one of the most common ingredients in moisturizers and in products labeled as gentle. Interest from a longevity angle comes from its role as a building block of a helper molecule the body uses to produce energy, a molecule that researchers are now studying in the biology of aging. At the same time, allergy specialists have begun asking whether this ingredient is as harmless as its reputation suggests.

This review examines what human studies show about panthenol for skin and wound repair, what is known about allergy and other harms, and whether any evidence bears on healthy aging for adults who already invest in their long-term health.

**[Benefits](#expected-benefits) - [Risks](#potential-risks--side-effects) - [Protocol](#therapeutic-protocol) - [Conclusion](#conclusion)**

  
## Recommended Reading

This section lists overview articles and research papers that discuss panthenol, or the vitamin B5 pathway it feeds, in depth.

<!-- Search statement: A real-time search was run on 2026-10-11 for high-level content on panthenol/dexpanthenol (and pantothenic acid as its active form). Web searches were run for each priority expert ("Rhonda Patrick", "Peter Attia", "Andrew Huberman", "Chris Kresser", "Life Extension", "lifespan.io" each combined with panthenol / pantothenic acid / vitamin B5). An on-site search of lifeextension.com via d-browser returned "Access Denied"; a domain-restricted web search of lifeextension.com returned only product pages, a cholesterol protocol and a 2015 cholesterol article about pantethine (a different compound), and a skin protocol mentioning pantothenic acid in one sentence — none discussed panthenol in depth. The FoundMyFitness site search for "panthenol" returned only the members-only episode "Q&A #32: Protein, mTOR & IGF-1—Plus Rhonda's Skincare Routine", whose public transcript names panthenol only once, in a list of skincare ingredients she uses daily; it was not listed because that passing mention is not an in-depth discussion. No relevant content was found from Peter Attia, Huberman Lab, Chris Kresser or Lifespan.io. PubMed searches identified narrative reviews and primary studies; systematic reviews were excluded here and listed in their own section. -->

- [Topical use of dexpanthenol: a 70th anniversary article](https://pubmed.ncbi.nlm.nih.gov/28503966/) - Proksch et al., 2017

  Narrative review of barrier, moisturizing and wound-healing studies. Three co-authors are Bayer Consumer Care employees; Bayer sells Bepanthen, so the review carries a direct commercial interest.

- [Topical use of dexpanthenol in skin disorders](https://pubmed.ncbi.nlm.nih.gov/12113650/) - Ebner et al., 2002

  Earlier overview of skin penetration, moisturizing, fibroblast (connective-tissue cell) and anti-inflammatory data plus placebo-controlled wound studies; useful for the pre-2002 clinical record that later reviews summarize only briefly.

- [Panthenol Allergic Contact Dermatitis: Sources of Exposure, Reported Cases, and a Call for More Frequent Testing](https://pubmed.ncbi.nlm.nih.gov/39714944/) - Weber & Hylwa, 2025

  Collects published allergy cases and patch-test rates, and lists "hypoallergenic" products containing panthenol — the main counterweight to its benign reputation.

- [Dexpanthenol: An Overview of its Contribution to Symptom Relief in Acute Rhinitis Treated with Decongestant Nasal Sprays](https://pubmed.ncbi.nlm.nih.gov/28695477/) - Mösges et al., 2017

  Post hoc (after-the-fact) analysis of a 152-patient double-blind trial of a decongestant spray with or without dexpanthenol; funded by Klosterfrau, which sells a combination spray.

- [Age-associated decline of Coenzyme A leads to intestinal stem cells dysfunction via disturbing iron homeostasis](https://pubmed.ncbi.nlm.nih.gov/40446021/) - Liu et al., 2025

  Fruit-fly study tying the pantothenate–coenzyme A pathway (how vitamin B5 becomes an energy-carrying helper molecule), which panthenol feeds, to stem-cell aging; coenzyme A supplementation extended lifespan, the closest mechanistic bridge to longevity.

No directly relevant content was found from Peter Attia, Andrew Huberman, Chris Kresser, Life Extension or Lifespan.io: web and site searches returned no articles, episodes or posts on panthenol, and Life Extension's vitamin B5 material concerns oral supplements or pantethine. Rhonda Patrick's FoundMyFitness site search matches panthenol only in a Q&A episode on her skincare routine, where she names it in passing among the ingredients she uses, without discussing it in depth.

  
## Grokipedia

<!-- Search statement: grokipedia.com was searched directly on 2026-10-11 using d-browser (first retrieval tier). The site's search page (grokipedia.com/search?q=panthenol) loaded, and the dedicated article grokipedia.com/page/Panthenol loaded with sections on chemistry, stereochemistry, synthesis and biological role. No further tiers were needed. -->

[Panthenol](https://grokipedia.com/page/Panthenol)

AI-generated encyclopedia entry covering chemistry, stereochemistry, synthesis, biological role and uses; convenient background, though its claims are best checked against the primary studies cited here.

  
## Examine

<!-- Search statement: examine.com was searched directly on 2026-10-11. Tier 1 d-browser returned a "Vercel Security Checkpoint" bot wall; tier 2 d-fetch returned HTTP 429; tier 3 d-proxy-1 loaded the site search. A search for "panthenol" returned "Sorry, there are no search results for panthenol." A search for "pantothenic acid" returned the dedicated page "Pantothenic Acid (Vitamin B5)" at /supplements/vitamin-b5/, the vitamin to which panthenol is converted; this page was loaded via d-proxy-1 and is cited. -->

[Pantothenic Acid (Vitamin B5)](https://examine.com/supplements/vitamin-b5/)

Examine has no panthenol page; this page covers the vitamin panthenol becomes, concluding most people get enough and extra oral supplementation shows little promise. Topical panthenol is not covered.

  
## ConsumerLab

<!-- Search statement: consumerlab.com was searched directly on 2026-10-11 using d-browser (tier 1), which loaded the site search. "panthenol" returned a single unrelated product review (menopause supplements) in which the term appears only in member text. "pantothenic acid" returned multi-product reviews (multivitamins, B vitamin supplements, nutritional yeast and others) and a ConsumerLab Answer on acne supplements, none dedicated to panthenol. No further tiers were needed. -->

No ConsumerLab article dedicated to panthenol exists. ConsumerLab mentions pantothenic acid only within broader multivitamin and B-vitamin product reviews.

  
## Systematic Reviews

This section lists systematic reviews that evaluated panthenol among other treatments; none is devoted to panthenol alone.

<!-- Search statement: PubMed was searched on 2026-10-11 with "(dexpanthenol OR panthenol) AND (systematic review[pt] OR meta-analysis[pt] OR "systematic review"[ti] OR "meta-analysis"[ti])" (5 hits) and with "(dexpanthenol OR panthenol OR "pantothenic acid") AND (systematic review OR meta-analysis)" (18 hits). Reviews that did not evaluate panthenol (e.g., B9/B12, metabolomics) and a narrative review were excluded. Four systematic reviews that included dexpanthenol trials remained, among them an ectoine review (Kauth & Trusova 2022) in which dexpanthenol was the comparator in one included trial. No systematic review or meta-analysis of panthenol's harms was found. -->

- [Topical interventions to prevent acute radiation dermatitis in head and neck cancer patients: a systematic review](https://pubmed.ncbi.nlm.nih.gov/27957620/) - Ferreira et al., 2017

  Thirteen randomized trials, dexpanthenol among the agents; no strong evidence that any topical product prevented radiation skin reactions better than controls.

- [Preventive and curative approaches to diaper dermatitis in children: a systematic review](https://pubmed.ncbi.nlm.nih.gov/41014074/) - Octarica et al., 2025

  Thirteen studies, 2,935 children; emollients containing zinc oxide or dexpanthenol were judged highly effective with minimal side effects. Infant evidence only.

- [Topical Ectoine Application in Children and Adults to Treat Inflammatory Diseases Associated with an Impaired Skin Barrier: A Systematic Review](https://pubmed.ncbi.nlm.nih.gov/35038127/) - Kauth & Trusova, 2022

  Six ectoine-cream studies; in one, ectoine matched dexpanthenol for skin irritation from the acne drug isotretinoin. Lead author works for ectoine maker Bitop.

- [Prevention of and therapies for nipple pain: a systematic review](https://pubmed.ncbi.nlm.nih.gov/16020410/) - Morland-Schultz & Hill, 2005

  Dexpanthenol was one of about a dozen nipple-pain treatments reviewed; no topical agent proved superior, and breastfeeding technique mattered most.

Panthenol's principal risk, allergic contact sensitization, is unrepresented: no systematic review or meta-analysis of it was found.

  
## Mechanism of Action

<!-- Word count target 150–250 (HTML comments excluded). -->

Panthenol is the alcohol form of pantothenic acid. Skin absorbs it well, especially from water-in-oil emulsions ([Ebner et al., 2002](https://pubmed.ncbi.nlm.nih.gov/12113650/)), and tissues convert it to pantothenic acid ([Proksch & Nissen, 2002](https://pubmed.ncbi.nlm.nih.gov/19753737/)). Pantothenic acid is the core of coenzyme A (CoA, a helper molecule that carries two-carbon units through energy metabolism and fat synthesis).

- **Barrier lipids:** CoA drives early steps in making fatty acids and sphingolipids (fats that seal the outer skin layer), the proposed basis for reduced water loss through the skin.
- **Water binding:** panthenol is a humectant (draws and holds water), so part of its effect may be physical.
- **Wound repair:** in experimental human skin wounds it shifted expression of inflammation and repair genes compared with placebo ([Heise et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22759998/)).
- **Bowel movement:** CoA supplies a building block of acetylcholine (the nerve messenger driving gut contractions), the rationale for injected use; the package insert calls the actual mode of action unknown ([Dexpanthenol package insert](https://www.drugs.com/pro/dexpanthenol.html)).
- **Competing view:** some benefit may come from the cream base itself; a vehicle-controlled trial found a difference on one of four skin measures ([Biro et al., 2003](https://pubmed.ncbi.nlm.nih.gov/14641355/)).

**Pharmacology:** panthenol has no receptor target, so selectivity does not apply; topical action stays mainly local. The label states human pharmacokinetic data (absorption, distribution, half-life) are unavailable; after 2 g intravenously, 10–30% appears in urine as pantothenic acid within 24 hours ([Sachs et al., 1990](https://pubmed.ncbi.nlm.nih.gov/2080639/)). No cytochrome P450 (liver drug-processing enzyme) involvement has been described.

  
## Historical Context & Evolution

<!-- Word count target 150–250 (HTML comments excluded). -->

Panthenol was developed as a stable form of pantothenic acid that penetrates skin. The first dexpanthenol ointment, Roche's Bepanthen, appeared in the late 1940s for minor wounds and irritated skin ([Proksch et al., 2017](https://pubmed.ncbi.nlm.nih.gov/28503966/); [Løkkevik et al., 1996](https://pubmed.ncbi.nlm.nih.gov/9023388/)); the brand is now marketed by Bayer.

A second use was internal. Because pantothenic acid feeds acetylcholine production, injectable dexpanthenol was given after abdominal surgery to prevent ileus (temporary paralysis of the bowel). A 1990 study confirmed that the injected drug is converted to pantothenic acid ([Sachs et al., 1990](https://pubmed.ncbi.nlm.nih.gov/2080639/)), but a 1994 randomized trial after cesarean section found that routine bowel stimulation with neostigmine (a drug that boosts acetylcholine) plus dexpanthenol did not speed bowel recovery and increased abdominal discomfort ([Costa et al., 1994](https://pubmed.ncbi.nlm.nih.gov/7941802/)). The U.S. injection is now listed as discontinued ([Dexpanthenol package insert](https://www.drugs.com/pro/dexpanthenol.html)).

Interest in aging predates both trends: a 1948 fruit-fly screen reported pantothenic acid as a longevity factor in royal jelly ([Gardner, 1948](https://pubmed.ncbi.nlm.nih.gov/18856647/)), and recent animal work on coenzyme A has revived the idea ([Liu et al., 2025](https://pubmed.ncbi.nlm.nih.gov/40446021/)).

Opinion has shifted on safety more than on efficacy. A 2002 review described minimal risk of sensitization ([Ebner et al., 2002](https://pubmed.ncbi.nlm.nih.gov/12113650/)); a 2025 review of newer patch-test series reports higher rates and calls for routine testing ([Weber & Hylwa, 2025](https://pubmed.ncbi.nlm.nih.gov/39714944/)). Both views rest on clinic-based series rather than population data, so neither is final.

  
## Expected Benefits

<!-- Search statement: Before writing, PubMed was searched on 2026-10-11 for "dexpanthenol randomized" (74 hits), "(dexpanthenol OR panthenol) AND review[pt] AND (skin OR topical OR wound)", "(dexpanthenol OR panthenol) AND (ileus OR intravenous OR intramuscular OR succinylcholine OR pharmacokinetics)", "(dexpanthenol OR panthenol) AND (mucositis OR xylometazoline OR photorefractive OR corneal epithelial OR tattoo OR hand eczema OR scar)", and "(pantothenic acid OR pantethine) AND (acne OR LDL OR lifespan OR aging)". Expert/clinical sources consulted: the Bayer-affiliated reviews (Proksch 2017, Gorski 2020, Cho 2022), the Ebner 2002 review, the dexpanthenol injection package insert and Examine's pantothenic acid page. The search specifically looked for null or opposite findings: the radiation-dermatitis trial (Løkkevik 1996) and systematic review (Ferreira 2017), the nipple-trauma trial (Shanazi 2015), the post-sinus-surgery trial (Tantilipikorn 2012), the saline-controlled dry-nose trial (Thieme 2020), the diaper-rash trial (Wananukul 2006), the dry-eye trial (Göbbels 1996), the vehicle-controlled corneal wound-healing trial (Baumeister 2009, found in a follow-up search of "(dexpanthenol OR panthenol) AND randomized controlled trial[pt]") and the cesarean bowel-stimulation trial (Costa 1994) are cited below. A corneal-injury comparison (Egger 1999) tested vitamin A plus dexpanthenol against a calf blood extract rather than dexpanthenol alone and is not cited. A follow-up search for "(dexpanthenol OR panthenol OR pantothenyl alcohol) AND constipation" identified the oral constipation review (Hanck & Goffin 1982), cited below, and a 1956 report on constipation in older adults without an abstract (Portella 1956), not cited. -->

### High 🟩 🟩 🟩

#### Faster healing of superficial wounds and post-procedure skin ⚠️ Conflicted

Dexpanthenol speeds re-epithelialization (regrowth of the surface cell layer) of minor wounds, per a Bayer-affiliated review ([Gorski et al., 2020](https://pubmed.ncbi.nlm.nih.gov/32610604/)). Independent groups found faster healing: Heise for carbon dioxide laser wounds versus petroleum jelly ([Heise et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30897983/)), Celebi for tonsil beds versus placebo ([Celebi et al., 2013](https://pubmed.ncbi.nlm.nih.gov/23951700/)) and Sabur for corneas ([Sabur & Acar, 2023](https://pubmed.ncbi.nlm.nih.gov/37306832/)). Baumeister's small trial found no significant corneal benefit versus ointment base ([Baumeister et al., 2009](https://pubmed.ncbi.nlm.nih.gov/19648776/)); cracked nipples healed no better than with lanolin ([Shanazi et al., 2015](https://pubmed.ncbi.nlm.nih.gov/26744729/)). Net: most controlled trials show faster healing.

**Magnitude:** Corneal re-epithelialization after cross-linking (a corneal-stiffening procedure) was complete in 2.24 days with dexpanthenol plus hyaluronate versus 3.43 days with hyaluronate alone in fellow eyes of 21 patients, about 1.2 days sooner ([Sabur & Acar, 2023](https://pubmed.ncbi.nlm.nih.gov/37306832/)).

#### Less throat pain after airway procedures ⭕️ Not Central to Health & Longevity

Dexpanthenol lozenges reduced throat pain in placebo-controlled trials from two independent groups: Gulhas and colleagues (Malatya) in 180 patients given a breathing tube (intubation) for surgery ([Gulhas et al., 2007](https://pubmed.ncbi.nlm.nih.gov/17073853/)), and Celebi and colleagues (Istanbul) in 120 children after tonsillectomy ([Celebi et al., 2013](https://pubmed.ncbi.nlm.nih.gov/23951700/)). The proposed mechanism is protection and repair of irritated throat lining. This bears on short-term comfort after anesthesia or throat surgery, not on long-term health or longevity.

**Magnitude:** Lower sore-throat incidence over 24 hours than placebo after a single 200 mg dose 30 minutes before intubation, and lower pain scores after tonsillectomy; the trial abstracts report statistical significance but no between-group outcome figure.

### Medium 🟩 🟩

#### Stronger skin barrier and protection from irritation

5% dexpanthenol preparations reduced transepidermal water loss (TEWL, water escaping through the skin, a measure of barrier leakiness) and raised hydration versus the vehicle in trials by Gehring and Gloor (Karlsruhe) ([Gehring & Gloor, 2000](https://pubmed.ncbi.nlm.nih.gov/10965426/)) and by Proksch and Nissen (Kiel), who also saw less redness after detergent irritation ([Proksch & Nissen, 2002](https://pubmed.ncbi.nlm.nih.gov/19753737/)); Biro and colleagues (Frankfurt) found hydration better preserved under detergent challenge ([Biro et al., 2003](https://pubmed.ncbi.nlm.nih.gov/14641355/)). Only one trial, in children, used a clinical endpoint with statistical testing ([İlhan et al., 2026](https://pubmed.ncbi.nlm.nih.gov/41566030/)), so High is not reached.

**Magnitude:** One preoperative application cut angular cheilitis (cracked mouth corners) on day 1 after adenotonsillectomy (removal of tonsils and adenoids) to 9.8% versus 44% without it (odds ratio 0.14, the ratio of the odds of cracking with versus without treatment; 95% CI, the range likely to contain the true value, 0.05–0.41); by week 1 rates were 3.9% versus 10% (not significant) ([İlhan et al., 2026](https://pubmed.ncbi.nlm.nih.gov/41566030/)).

#### Eczema control comparable to mild hydrocortisone

In atopic dermatitis (chronic itchy eczema), a 5% dexpanthenol ointment reduced severity as much as 1% hydrocortisone in a four-week half-body comparison in 26 children from one Bangkok group ([Udompataikul & Limpa-o-vart, 2012](https://pubmed.ncbi.nlm.nih.gov/22395588/)). Hydrocortisone cleared swelling faster in week 1. There was no placebo arm, so part of the effect may come from the ointment base. A consensus review recommending dexpanthenol for eczema was written with Bayer Korea staff ([Cho et al., 2022](https://pubmed.ncbi.nlm.nih.gov/35887707/)). Adult hand-eczema data use a multi-ingredient panthenol ointment ([Lueangarun et al., 2025](https://pubmed.ncbi.nlm.nih.gov/40078865/)).

**Magnitude:** SCORAD (a standard eczema severity score) fell similarly with dexpanthenol and hydrocortisone from baselines of 30.95 and 30.54, with no significant between-group difference; the abstract reports no between-group change figure ([Udompataikul & Limpa-o-vart, 2012](https://pubmed.ncbi.nlm.nih.gov/22395588/)).

### Low 🟩

#### Relief of dry or irritated nasal lining ⚠️ Conflicted

Dexpanthenol spray beat placebo on crusting and breathing resistance in dry nose ([Kehrl & Sonnemann, 1998](https://pubmed.ncbi.nlm.nih.gov/9795928/)); a hyaluronate combination matched saline in a trial co-authored by nasal-spray maker Ursapharm ([Thieme et al., 2020](https://pubmed.ncbi.nlm.nih.gov/32067777/)); post-sinus-surgery symptoms mostly matched saline ([Tantilipikorn et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22379743/)). Net: no consistent benefit; comparators and formulations differed.

**Magnitude:** After sinus surgery, mucociliary transit time (how fast the nose clears mucus) improved by 8.4 minutes with dexpanthenol versus 1.7 minutes with saline over six weeks ([Tantilipikorn et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22379743/)).

#### Faster recovery from acute rhinitis with a decongestant spray ⭕️ Not Central to Health & Longevity

Adding dexpanthenol to a xylometazoline (decongestant) spray improved nasal blockage, discharge and tolerability versus xylometazoline alone over five days in 152 patients with acute rhinitis (a head cold) ([Kehrl et al., 2003](https://pubmed.ncbi.nlm.nih.gov/12717602/)). Evidence is indirect: tested only together with the decongestant. This bears on short-term cold symptoms, not longevity.

**Magnitude:** After five days, 47% were cured with the combination versus 1% with xylometazoline alone, in a post hoc analysis funded by Klosterfrau, which sells the combination ([Mösges et al., 2017](https://pubmed.ncbi.nlm.nih.gov/28695477/)).

#### Dry-eye relief ⚠️ Conflicted

Dexpanthenol artificial tears improved corneal surface permeability versus identical drops without dexpanthenol in 50 dry-eye patients, but tear production, tear-film stability and symptoms did not differ ([Göbbels & Gross, 1996](https://pubmed.ncbi.nlm.nih.gov/8992089/)). Net: no symptom benefit shown.

**Magnitude:** No between-group difference in symptoms, Schirmer test (tear production) or tear break-up time over six weeks; only corneal permeability improved, and the abstract gives no figure ([Göbbels & Gross, 1996](https://pubmed.ncbi.nlm.nih.gov/8992089/)).

#### Prevention of radiation skin reactions ⚠️ Conflicted

Dexpanthenol cream became routine in some radiotherapy units, but a randomized within-patient trial in 86 patients found no clinically important benefit ([Løkkevik et al., 1996](https://pubmed.ncbi.nlm.nih.gov/9023388/)), and ectoine (a microbe-derived moisturizer) outperformed it in another ([Abd Elazim et al., 2023](https://pubmed.ncbi.nlm.nih.gov/37792331/)). Net: no protective effect shown.

**Magnitude:** No clinically important difference in skin-reaction grade, itching or pain versus untreated skin in the same field; the abstract reports no outcome figure ([Løkkevik et al., 1996](https://pubmed.ncbi.nlm.nih.gov/9023388/)).

#### Less hair shedding with injected dexpanthenol

Weekly intramuscular dexpanthenol alone was followed by better quality-of-life scores and hair satisfaction ([Kutlu & Metin, 2021](https://pubmed.ncbi.nlm.nih.gov/32960484/)), and with biotin by lower hair-fall counts ([Samadi et al., 2022](https://pubmed.ncbi.nlm.nih.gov/35791704/)). Neither study had a placebo group, and the biotin pairing makes the second indirect.

**Magnitude:** After weekly 500 mg injections, 57.1% of women with female-pattern hair loss reported being satisfied and 28.6% very satisfied (no control group) ([Kutlu & Metin, 2021](https://pubmed.ncbi.nlm.nih.gov/32960484/)).

#### Fewer acne lesions with oral pantothenic acid

A pantothenic acid-based supplement reduced facial acne lesions versus placebo over 12 weeks in 41 adults ([Yang et al., 2014](https://pubmed.ncbi.nlm.nih.gov/24831048/)). Evidence is indirect: an oral multi-ingredient product of the vitamin itself, not panthenol.

**Magnitude:** Significantly greater reduction in total lesion count than placebo at week 12; the abstract reports statistical significance but no between-group lesion figure ([Yang et al., 2014](https://pubmed.ncbi.nlm.nih.gov/24831048/)).

#### Lower blood cholesterol with pantethine

Pantethine, a coenzyme A precursor made from pantothenic acid, lowered LDL (low-density lipoprotein, the main artery-clogging cholesterol carrier) in a 32-person placebo-controlled trial; co-authors came from pantethine suppliers ([Evans et al., 2014](https://pubmed.ncbi.nlm.nih.gov/24600231/)). Evidence is indirect: pantethine is a different compound.

**Magnitude:** LDL fell 11% from baseline with 600–900 mg/day pantethine while placebo rose 3% by week 16, a significant between-group difference ([Evans et al., 2014](https://pubmed.ncbi.nlm.nih.gov/24600231/)).

#### Improved bowel movement in constipation and after surgery ⚠️ Conflicted

Oral dexpanthenol beat placebo for chronic constipation in two double-blind Roche trials, known only from a review ([Hanck & Goffin, 1982](https://pubmed.ncbi.nlm.nih.gov/6751051/)). Injected with neostigmine after cesarean section, it did not speed bowel recovery, an indirect test ([Costa et al., 1994](https://pubmed.ncbi.nlm.nih.gov/7941802/)). Net: no consistent gut-motility benefit.

**Magnitude:** First bowel movement on day 3 in 69.5% with neostigmine plus dexpanthenol versus 82.5% without bowel stimulation after cesarean section; the constipation review reports no outcome figure ([Costa et al., 1994](https://pubmed.ncbi.nlm.nih.gov/7941802/); [Hanck & Goffin, 1982](https://pubmed.ncbi.nlm.nih.gov/6751051/)).

#### Faster recovery of diaper rash ⭕️ Not Central to Health & Longevity ⚠️ Conflicted

In 46 infants with diarrhea-related diaper rash, a dexpanthenol–zinc oxide ointment improved skin water loss by day 3 but not severity or clearance versus the base ointment ([Wananukul et al., 2006](https://pubmed.ncbi.nlm.nih.gov/17128840/)). Evidence is indirect: tested only with zinc oxide. This bears on infant care. Net: no faster clearance shown.

**Magnitude:** Complete clearance by day 7 on 58.7% of treated sides versus 56% of base-ointment sides, not significantly different ([Wananukul et al., 2006](https://pubmed.ncbi.nlm.nih.gov/17128840/)).

### Speculative 🟨

#### Slower aging through coenzyme A support

Pantothenic acid protected against aging-related decline in worms ([Jonk et al., 2025](https://pubmed.ncbi.nlm.nih.gov/40544604/)); coenzyme A extended fly lifespan ([Liu et al., 2025](https://pubmed.ncbi.nlm.nih.gov/40446021/)). Basis is animal-only, with related compounds.

  
## Benefit-Modifying Factors

- **Genetic polymorphisms:** No common variant is known to change skin effects. In rare PANK2 mutations (gene for pantothenate kinase, the first enzyme converting pantothenic acid to coenzyme A), panthenol cannot feed the pathway; a fly model responded to pantethine ([Rana et al., 2010](https://pubmed.ncbi.nlm.nih.gov/20351285/)).
- **Baseline biomarkers:** Effects show mainly on dry, irritated or wounded skin; in a vehicle-controlled trial, the only significant difference from the cream base appeared after detergent irritation ([Biro et al., 2003](https://pubmed.ncbi.nlm.nih.gov/14641355/)).
- **Sex:** No sex-based differences in benefit have been reported; most trials pooled men and women without separate analysis.
- **Pre-existing conditions:** Eczema, laser-treated skin and minor wounds show benefit; radiotherapy skin reactions do not ([Løkkevik et al., 1996](https://pubmed.ncbi.nlm.nih.gov/9023388/)).
- **Age:** Older adults often have xerosis (chronically dry, rough skin) and slower barrier repair, the setting where moisturizing ingredients are most used; panthenol has not been tested separately in older adults.
- **Formulation:** Water-in-oil emulsions deliver more panthenol into skin than simple solutions ([Ebner et al., 2002](https://pubmed.ncbi.nlm.nih.gov/12113650/)).

  
## Potential Risks & Side Effects

<!-- Search statement: Before writing, the dexpanthenol injection package insert (Drugs.com reproduction of the American Regent label) was reviewed as the drug reference source, together with Examine's pantothenic acid page and the Cosmetic Ingredient Review safety assessment (Scott 2022). PubMed was searched on 2026-10-11 for "(panthenol OR dexpanthenol) AND (contact dermatitis OR allergy OR anaphylaxis OR urticaria OR patch test)" (72 hits) and "pantothenic acid biotin eosinophilic pleuropericarditis". The search also looked for studies finding no excess risk: the placebo- and vehicle-controlled trials (Biro 2003, Udompataikul 2012, Abd Elazim 2023, Stettler 2017 in infants) reported no or similar adverse events, and the Cosmetic Ingredient Review panel judged panthenol safe as used in cosmetics. An in-vitro study of human nasal ciliary beat frequency (Behr 2023) is listed as Speculative. -->

### High 🟥 🟥 🟥

No risk reaches High: the recorded harms come from case reports, patch-test clinic series and label reports, not from controlled trials by more than one group.

### Medium 🟥 🟥

No risk reaches Medium: the only controlled finding of harm is indirect, from a trial that gave dexpanthenol only with neostigmine, while panthenol-only trials report good tolerability.

### Low 🟥

#### Allergic contact dermatitis and hives

Panthenol can sensitize skin, causing itchy eczema where applied or delayed wound healing ([Coco-Viloin et al., 2024](https://pubmed.ncbi.nlm.nih.gov/39129125/)) and occasionally hives (contact urticaria) ([Weber & Hylwa, 2025](https://pubmed.ncbi.nlm.nih.gov/39714944/)). Cases often trace to "hypoallergenic" products ([Han & Warshaw, 2023](https://pubmed.ncbi.nlm.nih.gov/36705646/)).

**Magnitude:** 26 of 2,171 patients (1.2%) patch-tested in Coimbra reacted to dexpanthenol, with relevance traced in 76.9% (no control group) ([Fernandes et al., 2018](https://pubmed.ncbi.nlm.nih.gov/30009460/)); earlier patch-test series reported 0.2–0.7% (no control group), as summarized in a review ([Weber & Hylwa, 2025](https://pubmed.ncbi.nlm.nih.gov/39714944/)).

#### Severe whole-body allergic reaction after oral exposure

Dexpanthenol in oral multivitamin tablets was reported to trigger anaphylaxis (a sudden, life-threatening whole-body allergic reaction) ([Röckmann et al., 2005](https://pubmed.ncbi.nlm.nih.gov/16197399/)). The evidence is a single case report, so its frequency is unknown.

**Magnitude:** Not quantified in available studies. Only a single case report exists, with no comparison group.

#### Reactions to injected dexpanthenol

The label lists rare allergic reactions, some with antibiotics, opioids (strong painkillers) or barbiturates (sedatives), prolonged effect of succinylcholine (an anesthesia muscle relaxant), and single reports of low blood pressure, colic, vomiting and agitation; causality is uncertain ([Dexpanthenol package insert](https://www.drugs.com/pro/dexpanthenol.html)). A weekly-injection series reported none ([Kutlu & Metin, 2021](https://pubmed.ncbi.nlm.nih.gov/32960484/)).

**Magnitude:** Not quantified in available studies. Only isolated label reports exist, without denominators or a comparison group.

#### Abdominal discomfort with prophylactic bowel stimulation

After cesarean section, routine neostigmine plus dexpanthenol increased abdominal discomfort needing treatment without speeding bowel recovery ([Costa et al., 1994](https://pubmed.ncbi.nlm.nih.gov/7941802/)). Evidence is indirect: dexpanthenol was given only with neostigmine.

**Magnitude:** 50% of women given neostigmine plus dexpanthenol versus 22.5% of women without stimulation needed treatment for abdominal discomfort ([Costa et al., 1994](https://pubmed.ncbi.nlm.nih.gov/7941802/)).

#### Inflammation around heart and lungs with oral vitamin B5 plus biotin

A 76-year-old woman taking vitamins B5 and H (biotin) for two months developed eosinophilic pleuropericarditis (life-threatening inflammatory fluid around heart and lungs with high eosinophils, allergy-type white cells); it resolved after stopping ([Debourdeau et al., 2001](https://pubmed.ncbi.nlm.nih.gov/11302404/)). Single case, oral pantothenic acid with biotin.

**Magnitude:** Not quantified in available studies. Only a single case report exists, with no comparison group.

### Speculative 🟨

#### Slowed nasal ciliary beating with nasal products

In lab-grown human nasal cells, Bepanthen and dexpanthenol at clinical concentrations slowed the beating of cilia (hair-like structures sweeping out mucus) ([Behr et al., 2023](https://pubmed.ncbi.nlm.nih.gov/36920556/)). The basis is one in-vitro study; clinical relevance is unknown.

  
## Risk-Modifying Factors

- **Genetic polymorphisms:** No gene variant is known to alter panthenol risk; a tendency to multiple contact allergies matters more: 25 of 26 dexpanthenol-allergic patients reacted to other allergens ([Fernandes et al., 2018](https://pubmed.ncbi.nlm.nih.gov/30009460/)).
- **Baseline biomarkers:** A positive patch test to dexpanthenol identifies those at risk; no blood marker predicts reactions.
- **Sex:** No sex-based difference in panthenol allergy or other harms has been reported.
- **Pre-existing conditions:** Chronic eczema and damaged skin are the usual setting of sensitization: 88.5% of allergic patients were tested for chronic eczema, though the series had no comparison group ([Fernandes et al., 2018](https://pubmed.ncbi.nlm.nih.gov/30009460/)).
- **Age:** Older adults with leg ulcers or long-term eczema accumulate exposure; the injection label reports agitation in one elderly patient ([Dexpanthenol package insert](https://www.drugs.com/pro/dexpanthenol.html)).

  
## Key Interactions & Contraindications

<!-- Search statement: Before writing, PubMed was searched on 2026-10-11 for "(dexpanthenol OR panthenol) AND (ileus OR intravenous OR intramuscular OR succinylcholine OR pharmacokinetics)" and "(dexpanthenol OR panthenol) AND (xylometazoline ...)", and the injection package insert's interaction section was reviewed. No formal human pharmacokinetic interaction study of panthenol was found; the only human data are the label's succinylcholine report, the antibiotic/opioid/barbiturate allergy note, the neostigmine-combination trial (Costa 1994), the decongestant-combination trial (Kehrl 2003) and a biotin case report (Debourdeau 2001). Other interactions are marked theoretical. -->

- **Succinylcholine (depolarizing muscle relaxant used in anesthesia):** Caution — the label reports prolonged paralysis and advises against giving injected dexpanthenol within one hour of succinylcholine ([Dexpanthenol package insert](https://www.drugs.com/pro/dexpanthenol.html)). Topical use is not implicated.
- **Cholinesterase inhibitors (drugs that raise acetylcholine: neostigmine, donepezil, rivastigmine):** Monitor — combined with neostigmine, injected dexpanthenol increased abdominal discomfort ([Costa et al., 1994](https://pubmed.ncbi.nlm.nih.gov/7941802/)); an additive effect with donepezil or rivastigmine is theoretical.
- **Antibiotics, opioids and barbiturates (e.g., cefazolin, morphine, phenobarbital):** Caution — rare allergic reactions occurred with injected dexpanthenol given alongside; the label directs stopping at any sign of hypersensitivity ([Dexpanthenol package insert](https://www.drugs.com/pro/dexpanthenol.html)).
- **Decongestant nasal sprays (sympathomimetics, which shrink swollen nasal vessels: xylometazoline, oxymetazoline):** Favorable combination — adding dexpanthenol improved symptoms and tolerability versus xylometazoline alone over five days ([Kehrl et al., 2003](https://pubmed.ncbi.nlm.nih.gov/12717602/)). Decongestant time limits still apply.
- **Biotin supplements:** Monitor — one eosinophilic pleuropericarditis case followed oral vitamin B5 plus biotin ([Debourdeau et al., 2001](https://pubmed.ncbi.nlm.nih.gov/11302404/)); new chest pain or breathlessness warrants medical review.
- **Pantothenic acid, pantethine or B-complex supplements:** Additive (theoretical); monitor in dexpanthenol allergy — same coenzyme A pathway; no harm reported otherwise, and oral pantothenic acid kept hand eczema active in a dexpanthenol-allergic patient ([Hemmer et al., 1997](https://pubmed.ncbi.nlm.nih.gov/9255501/)).
- **Other barrier ingredients (madecassoside, bisabolol, ceramides):** Additive (theoretical) — often co-formulated after laser procedures; a panthenol mask with madecassoside and bisabolol improved post-laser barrier recovery versus a saline dressing ([Gao et al., 2025](https://pubmed.ncbi.nlm.nih.gov/40613435/)), but panthenol's share is unknown.
- **Multiple panthenol-containing cosmetics:** Caution (theoretical) — stacking moisturizers, shampoos and "sensitive skin" products raises cumulative exposure and may raise sensitization risk ([Weber & Hylwa, 2025](https://pubmed.ncbi.nlm.nih.gov/39714944/)).

**Populations who should avoid Panthenol:**

- People with a positive patch test to dexpanthenol 5% in petroleum jelly ([Fernandes et al., 2018](https://pubmed.ncbi.nlm.nih.gov/30009460/))
- Injected form: anyone who received succinylcholine within the previous hour ([Dexpanthenol package insert](https://www.drugs.com/pro/dexpanthenol.html))
- Injected form in pregnancy (Category C, a former U.S. label class used when safety in pregnancy has not been established) unless clearly needed ([Dexpanthenol package insert](https://www.drugs.com/pro/dexpanthenol.html))

  
## Risk Mitigation Strategies

Doses and timings below follow common practice unless cited.

- **Small-area trial before broad use:** applying a new panthenol product to a small forearm patch twice daily for about one week before face or wound use confines any allergic contact dermatitis to a small area.
- **Stopping and patch testing at the first rash:** if itch or eczema worsens under treatment, pausing all panthenol products and patch testing with dexpanthenol 5% in petroleum jelly identifies allergic contact dermatitis ([Fernandes et al., 2018](https://pubmed.ncbi.nlm.nih.gov/30009460/)).
- **Label checks on "hypoallergenic" products:** after a confirmed allergy, scanning ingredient lists for panthenol, D-panthenol or dexpanthenol prevents re-exposure; such products are a documented hidden source of persistent dermatitis ([Han & Warshaw, 2023](https://pubmed.ncbi.nlm.nih.gov/36705646/)).
- **Spacing injections from succinylcholine:** at least one hour apart, which avoids prolonged paralysis and breathing difficulty ([Dexpanthenol package insert](https://www.drugs.com/pro/dexpanthenol.html)).
- **Chest-symptom watch with oral B5 plus biotin:** chest pain or breathlessness, the presenting signs of eosinophilic pleuropericarditis, is the threshold for stopping and medical review ([Debourdeau et al., 2001](https://pubmed.ncbi.nlm.nih.gov/11302404/)).

  
## Therapeutic Protocol

Other parameters without a citation (e.g., timing, cycling, duration) reflect common practice.

- **Skin barrier and dry skin:** 5% dexpanthenol cream or ointment twice daily, as in vehicle-controlled trials ([Proksch & Nissen, 2002](https://pubmed.ncbi.nlm.nih.gov/19753737/); [Biro et al., 2003](https://pubmed.ncbi.nlm.nih.gov/14641355/)); popularized through Roche's and later Bayer's Bepanthen line ([Proksch et al., 2017](https://pubmed.ncbi.nlm.nih.gov/28503966/)).
- **Post-procedure wounds:** dexpanthenol ointment under a sealed dressing for 7 days after fractional laser resurfacing, as in an Aachen university trial ([Heise et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30897983/)).
- **Competing approaches:** petroleum jelly alone for wounds ([Heise et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30897983/)), 1% hydrocortisone for eczema flares ([Udompataikul & Limpa-o-vart, 2012](https://pubmed.ncbi.nlm.nih.gov/22395588/)), and ectoine 7% cream for radiotherapy skin ([Abd Elazim et al., 2023](https://pubmed.ncbi.nlm.nih.gov/37792331/)) are alternatives; none is the default.
- **Nasal lining:** dexpanthenol nasal spray four times daily for six weeks after sinus surgery ([Tantilipikorn et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22379743/)).
- **Eyes:** dexpanthenol 2%/hyaluronate 0.15% eye drops after corneal procedures ([Sabur & Acar, 2023](https://pubmed.ncbi.nlm.nih.gov/37306832/)).
- **Throat:** 200 mg dexpanthenol as two pastilles 30 minutes before intubation ([Gulhas et al., 2007](https://pubmed.ncbi.nlm.nih.gov/17073853/)).
- **Injection (clinical settings only):** 250–500 mg intramuscularly, repeated at 2 hours then every 6 hours for ileus ([Dexpanthenol package insert](https://www.drugs.com/pro/dexpanthenol.html)); 500 mg weekly in a hair-loss series ([Kutlu & Metin, 2021](https://pubmed.ncbi.nlm.nih.gov/32960484/)).
- **Oral use:** no panthenol dose for longevity exists; Examine finds extra oral pantothenic acid of little promise for people with adequate diets ([Examine](https://examine.com/supplements/vitamin-b5/)).
- **Time of day:** no circadian data; topical products are usually applied morning and evening, with the evening application benefiting from overnight contact.
- **Half-life:** human pharmacokinetic data are unavailable; after 2 g intravenously, 10–30% is excreted in urine within 24 hours ([Sachs et al., 1990](https://pubmed.ncbi.nlm.nih.gov/2080639/)).
- **Single versus split dosing:** topical effects are local and short-lived, so twice-daily application is standard; label injections are repeated every 6 hours.
- **Genetic polymorphisms:** no pharmacogenetic variants guide dosing; in the inherited brain disorder caused by PANK2 mutations, the enzyme starting coenzyme A synthesis from pantothenic acid is impaired, and a fly model was rescued by pantethine ([Rana et al., 2010](https://pubmed.ncbi.nlm.nih.gov/20351285/)).
- **Sex:** no sex-based dosing differences are reported; the same concentrations were used in men and women.
- **Age:** older adults with dry skin may need more frequent application; infant tolerability of a panthenol emollient was good in a study by Bayer staff ([Stettler et al., 2017](https://pubmed.ncbi.nlm.nih.gov/27545858/)).
- **Baseline biomarkers:** high skin water loss marks a damaged barrier where effects are largest; a positive dexpanthenol patch test excludes use.
- **Pre-existing conditions:** eczema, laser-treated or wounded skin are the main indications; radiotherapy skin and dry eye showed no clear benefit.

  
## Discontinuation & Cycling

- **Duration:** Topical panthenol is used short term for wounds or flares, or long term as a moisturizer; no lifelong regimen is defined.
- **Withdrawal effects:** None are known; stopping simply ends the local moisturizing effect.
- **Tapering:** Not needed; topical and injected forms can be stopped at once.
- **Injected course:** For ileus the label continues dosing "until all danger of adynamic ileus has passed" ([Dexpanthenol package insert](https://www.drugs.com/pro/dexpanthenol.html)).
- **Cycling:** No evidence supports cycling to maintain efficacy; no tolerance has been described.

  
## Sourcing and Quality

- **Form:** Dexpanthenol (D-panthenol) is the vitamin-active form; DL-panthenol is a racemic mixture (equal right- and left-handed molecules) in which only the D half converts to pantothenic acid ([Grokipedia entry on panthenol](https://grokipedia.com/page/Panthenol)).
- **Concentration and vehicle:** Clinical trials used 5% dexpanthenol in creams and ointments; water-in-oil emulsions improve skin penetration ([Ebner et al., 2002](https://pubmed.ncbi.nlm.nih.gov/12113650/)).
- **Branded versus cosmetic products:** Branded dexpanthenol ointments (e.g., Bepanthen) declare their dexpanthenol content; cosmetic panthenol content is often unstated. Cosmetic Ingredient Review, funded by the cosmetics industry, judged panthenol safe as used ([Scott et al., 2022](https://pubmed.ncbi.nlm.nih.gov/36177798/)).
- **Eye and nasal products:** Preservative-free eye drops avoid preservative irritation; nasal sprays come as dexpanthenol alone or with a decongestant.
- **Reputable brands:** Bepanthen/Bepanthol (Bayer), La Roche-Posay Cicaplast Baume B5, Nasic/Nasicur nasal sprays (Klosterfrau) and dexpanthenol–hyaluronate eye drops such as Hylo or Hylopan are widely available.
- **Oral supplements:** For calcium pantothenate products, a third-party verification seal (e.g., from USP, the United States Pharmacopeia, or NSF, an independent product certifier) confirms stated content and purity.

  
## Practical Considerations

- **Time to effect:** Laser wounds closed faster within 1–2 days ([Heise et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30897983/)); barrier and hydration changes appear within one week ([Gehring & Gloor, 2000](https://pubmed.ncbi.nlm.nih.gov/10965426/)); eczema improved over 2–4 weeks ([Udompataikul & Limpa-o-vart, 2012](https://pubmed.ncbi.nlm.nih.gov/22395588/)).
- **Common pitfalls:** Assuming "hypoallergenic" products are panthenol-free; confusing panthenol with pantethine, whose cholesterol data do not transfer; expecting radiation-skin protection; and choosing DL-panthenol products when D-panthenol is intended.
- **Regulatory status:** Topical panthenol is used mainly as a cosmetic ingredient, assessed for safety by the industry-funded Cosmetic Ingredient Review panel ([Scott et al., 2022](https://pubmed.ncbi.nlm.nih.gov/36177798/)). The U.S. injection is listed as an unapproved, now discontinued prescription drug ([Dexpanthenol package insert](https://www.drugs.com/pro/dexpanthenol.html)).
- **Cost and access:** Inexpensive and widely available; cost does not limit use.

  
## Interaction with Foundational Habits

- **Sleep:** No direct interaction; no effect on sleep has been reported. Indirectly, reducing itch in eczema may improve sleep, and evening application gives the longest undisturbed skin contact.
- **Nutrition:** No direct interaction; most people consume adequate pantothenic acid, and extra oral intake shows little promise ([Examine](https://examine.com/supplements/vitamin-b5/)); topical panthenol is not known to alter dietary needs. Oral pantothenic acid can maintain eczema in panthenol-allergic people ([Hemmer et al., 1997](https://pubmed.ncbi.nlm.nih.gov/9255501/)).
- **Exercise:** No direct interaction with training or recovery. Practically, it is used on friction- or sweat-irritated skin; repeated hand washing or detergent exposure is the setting where barrier protection was shown ([Biro et al., 2003](https://pubmed.ncbi.nlm.nih.gov/14641355/)).
- **Stress management:** No interaction with cortisol or the stress response has been reported; any effect is indirect, through relief of itch or skin discomfort.

  
## Monitoring Protocol & Defining Success

Before starting, no laboratory tests are required for topical panthenol. People with chronic eczema, multiple known contact allergies or a previous reaction to skin products benefit from a baseline patch test that includes dexpanthenol. Where a dermatology clinic offers it, a baseline measurement of skin water loss and hydration at the treated site allows later comparison. Photographs of wounds or problem areas give a simple baseline.

Ongoing monitoring follows the use: wound healing is typically reviewed at days 2, 5 and 14; dry skin or eczema is reassessed at 2 and 4 weeks, then every 3–6 months during long-term use. Any new rash, itch or delayed healing is the signal for a pause and patch testing. For those on oral pantothenic acid with biotin who develop chest symptoms, a blood count with eosinophils is the relevant test. Success means less dryness, faster closure and no new rash.

| Biomarker | Optimal Functional Range | Why Measure It? | Context/Notes |
|---|---|---|---|
| Patch test to dexpanthenol 5% in petroleum jelly | No established target; track whether the reaction is negative or positive | Safety check: a positive result stops use | Readings at day 2 and day 3–4; include personal products tested "as is" ([Fernandes et al., 2018](https://pubmed.ncbi.nlm.nih.gov/30009460/); [Weber & Hylwa, 2025](https://pubmed.ncbi.nlm.nih.gov/39714944/)) |
| Transepidermal water loss (TEWL) | No established target; track change from own baseline at the same site | Expected to fall as the barrier recovers | Rest 15–30 minutes in a stable room first; no products on the site for 12 hours; used as endpoint in [Gehring & Gloor, 2000](https://pubmed.ncbi.nlm.nih.gov/10965426/) |
| Outer skin layer hydration (corneometry, an electrical skin-moisture reading) | No established target; track change from own baseline | Expected to rise with use | Same conditions as TEWL; best paired with it; used as endpoint in [Biro et al., 2003](https://pubmed.ncbi.nlm.nih.gov/14641355/) |
| Blood eosinophil count (only for oral vitamin B5 with biotin and chest symptoms) | 0–500 cells/µL (standard reference range) | Safety check: a high count with chest symptoms stops use | Not fasting-dependent; the reported case had 1,200–1,500 cells/mm³ ([Debourdeau et al., 2001](https://pubmed.ncbi.nlm.nih.gov/11302404/)) |

Qualitative markers:

- Skin dryness, roughness and scaling at treated sites
- Itch intensity, including night-time itch
- Speed of wound closure and cosmetic appearance after procedures
- Nasal crusting and ease of breathing (for nasal use)
- New redness, rash or eczema where products are applied (safety signal)

  
## Emerging Research

- **Injected dexpanthenol for chronic wounds:** A randomized trial ([NCT07395674](https://clinicaltrials.gov/study/NCT07395674)) will add injections around diabetic, venous or arterial ulcers to standard care in 40 adults; primary endpoint wound-area change; not yet recruiting, completion 2028. Positive results would support injection around chronic wounds; null results would confine benefit to minor wounds.
- **Medicated hydrogel patch for abrasions:** A manufacturer-sponsored (Wooshin Labottach) randomized trial ([NCT07642973](https://clinicaltrials.gov/study/NCT07642973)) compares a dexpanthenol hydrogel plaster with a standard plaster in 40 people; primary endpoint re-epithelialization rate. Positive results would strengthen the wound-healing grade; null results would weaken it.
- **Eye drops after cataract surgery:** A 300-patient comparison ([NCT07581548](https://clinicaltrials.gov/study/NCT07581548)) tests dexpanthenol–hyaluronate drops against trehalose and amino-acid drops on dry-eye scores; completion 2027. Superiority would revive the dry-eye case; equivalence would confirm no specific benefit.
- **Moisturizers for cancer-therapy skin toxicity:** A 50-participant non-randomized Stanford study ([NCT07767448](https://clinicaltrials.gov/study/NCT07767448)), co-sponsored by L'Oréal, maker of the tested La Roche-Posay products, includes a panthenol balm; completion 2029. Improvement would support supportive-care use, though without a control; no change would argue against it.
- **Overdue corneal trial:** A randomized fellow-eye trial after laser eye surgery (photorefractive keratectomy) ([NCT06822608](https://clinicaltrials.gov/study/NCT06822608)) had a registered completion of January 2026 that has passed; the record still reads "not yet recruiting" and no results are posted.
- **Coenzyme A and aging:** Animal work links falling coenzyme A to stem-cell aging ([Liu et al., 2025](https://pubmed.ncbi.nlm.nih.gov/40446021/)) and pantothenic acid to worm healthspan ([Jonk et al., 2025](https://pubmed.ncbi.nlm.nih.gov/40544604/)); human trials of panthenol on aging markers do not exist.
- **Allergy surveillance:** Rising patch-test positivity ([Weber & Hylwa, 2025](https://pubmed.ncbi.nlm.nih.gov/39714944/)) and calls for routine testing ([Ahuja & Nedorost, 2024](https://pubmed.ncbi.nlm.nih.gov/38466988/)) could show panthenol allergy is more common, weakening its safety profile.
- **Radiation dermatitis:** Existing trials and a systematic review found no protection ([Ferreira et al., 2017](https://pubmed.ncbi.nlm.nih.gov/27957620/)); further trials would mainly test comparators such as ectoine ([Abd Elazim et al., 2023](https://pubmed.ncbi.nlm.nih.gov/37792331/)).

  
## Conclusion

Panthenol is a form of vitamin B5 that the body converts into the vitamin, and it is used mainly on the skin and other body surfaces. Its best-supported effects are local: faster closure of minor wounds such as laser-treated skin, less throat soreness after breathing-tube placement or tonsil surgery, and a better-hydrated, more resilient skin barrier. Eczema relief matched a mild steroid cream in a single small comparison; evidence for dry nasal lining, hair shedding and acne is thinner still, and well-designed comparisons found no protection against radiation skin reactions and no relief of dry-eye symptoms. Claims about cholesterol and aging rest on related compounds or on animal studies, not on panthenol itself.

The risks are mostly minor. The main one is skin allergy, which appears more common than once assumed and can hide in products marketed as gentle. Injected forms carry rare allergic reactions and an interaction with a muscle relaxant used in anesthesia, but injections are rarely relevant outside hospitals.

The evidence base is small, often old, and frequently produced or summarized by companies that sell panthenol products, including the makers of leading skin creams and nasal sprays, and the main cosmetic safety assessment comes from a panel funded by the cosmetics industry. For health-focused adults, panthenol emerges as a low-cost, low-risk skin-care ingredient with modest local benefits and no human evidence of an effect on aging itself.

**[Top](#top) - [Benefits](#expected-benefits) - [Risks](#potential-risks--side-effects) - [Protocol](#therapeutic-protocol)**


